Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F1BE3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,947
Award facts
- Contract value 100% obligated
- $13,946.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,946.68 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on February 4, 2026, for Benlysta 200 mg/mL auto-injector pharmaceutical supply. This is a firm fixed-price delivery order with no set-aside designation, utilizing a competitive procurement process. The place of performance is Conshohocken, Pennsylvania, with an ultimate completion date of February 26, 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement and operates as a subsidiary of Cencora, Inc., a major healthcare solutions provider in the federal supply chain.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The contract supports critical federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's established capability to fulfill specialized pharmaceutical requirements for military treatment facilities and other government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F1BE3?
SPE2DR26F1BE3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F1BE3 worth?
The government has obligated $13,947 on SPE2DR26F1BE3.
Is contract SPE2DR26F1BE3 an order under another contract?
Yes. SPE2DR26F1BE3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1BE3 competed?
The extent of competition for SPE2DR26F1BE3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award